EDGAR Filing Documents for 0000950170-24-097575

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:

SEC Accession No. 0000950170-24-097575

Filing Date

2024-08-15

Accepted

2024-08-15 16:15:02

Documents

Period of Report

2024-06-30

Effectiveness Date

2024-08-15

Document Format Files

Seq	Description	Document	Type	Size
1	NT 10-Q	atx_nt_10-q_06.30.2024.htm	NT 10-Q	44654
	Complete submission text file	0000950170-24-097575.txt		45928

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210

Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: NT 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 241212601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)